169032-11-5Relevant articles and documents
Regio-selective synthesis of key intermediates of fexofenadine
Kumar, Anil,Bhashkar, Bhuwan,Kumar, Harish,Singh, Gurpreet
, p. 2285 - 2287 (2015/12/19)
The present work is focused on improved process of preparation of fexofenadine which is achieved by regio-selective synthesis of intermediate; 1-oxoalkoxy-2-methyl-2-[4-(4-chloro-1-oxobutyl)phenyl]propane. The said intermediate is prepared in good yields and with greater purity wherein the synthesis of side products like 1-oxoalkoxy-2-methyl-2-[3-(4-chloro-1-oxobutyl)phenyl]propane (metaisomer) is reduced to a great amount. The intermediate, 1-oxoalkoxy-2-methyl-2-[4-(4-chloro-1-oxobutyl)phenyl]propane (para-isomer) where, alkyl group is selected from C2-5 carbon chain, is synthesized through preparation of 1-chloro-2-methyl-2-phenylpropane which upon reaction with potassium salt of aliphatic carboxylic acid followed by Friedel-Crafts acylation with 4-chlorobutyrylchloride results into desired intermediate, 1-oxoalkoxy-2-methyl-2-[4-(4-chloro-1-oxobutyl)phenyl]propane and a side impurity, 1-oxoalkoxy-2-methyl-2-[3-(4-chloro-1-oxobutyl)phenyl]propane (meta-isomer) in the ratio of 1:0.09-0.15. The above said mixture can be directly used for the synthesis of fexofenadine and has an advantage of eliminating the purification process at intermediate stage and use of less volume of expensive solvents.
Synthesis of [2H5]-ebastine fumarate and [ 2H5]-hydroxyebastine
Yu, Zhoujie,Wang, Wei,Chen, Liqin
, p. 352 - 356 (2012/06/01)
This study describes the synthesis of deuterium-labelled ebastine fumarate and its deuterium-labelled metabolite hydroxyebastine. The synthesis of the two desired compounds both used [2H5]-bromodiphenylmethane as deuterium-labelled reagent, which was synthesized beforehand in three steps. [2H5]-ebastine was synthesized in further three steps with a 27% overall yield and [2H5]-hydroxyebastine was synthesized in further seven steps with a 13% overall yield.
Intermediates useful for the preparation of antihistaminic piperidine derivatives
-
Page column 87, (2008/06/13)
The present invention is related to a novel intermediates and processes which are useful in the preparation of certain antihistaminic piperidine derivatives of the formula whereinW represents —C(=O)— or —CH(OH)—;R1 represents hydrogen or hydroxy;R2 represents hydrogen;R1 and R2 taken together form a second bond between the carbon atoms bearing R1 and R2;n is an integer of from 1 to 5;m is an integer 0 or 1;R3 is —COOH or —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched each of A is hydrogen or hydroxy; andpharmaceutically acceptable salts and individual optical isomers thereof, with the proviso that where R1 and R2 are taken together to form a second bond between the carbon atoms bearing R1 and R2 or where R1 represented hydroxy, m is an integer 0.